David Fitchett

Also affiliated with University of Toronto

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes”.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine(2015)10.1056/nejmoa1504720

N/A

1.4DataRank · unranked

11839 citations

Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel +7 more

Early Benefits of Empagliflozin in Patients with or Without Heart Failure: Findings from EMPA-REG OUTCOME

ESC Heart Failure(2020)10.1002/ehf2.12891

N/A

0DataRank · unranked

20 citations

Anne Pernille Ofstad, David Fitchett, Cordula Zeller, Christoph Wanner, Jyothis T. George +4 more